What is the rationale and evidence behind dose optimization approaches in CLL treatment, including dose escalation and dose reduction? What are strategies for dose modifications to mitigate adverse events while maintaining treatment efficacy? What role does patient education play in recognizing and managing CLL treatment-related side effects?
Join Dr. Andres Chang of Emory Healthcare and Dr. Daniel A. Ermann of Huntsman Cancer Institute, as they discuss optimizing CLL care. Discover effective communication strategies to empower your CLL patients during their treatment journey.
Topics:
- Understanding dose escalation and dose reduction in CLL
- Optimizing CLL treatment efficacy while minimizing toxicity and immunosuppression
- Dose-dependent side effects in CLL
- HCP-to-HCP recommended strategies for CLL side effect management
Register to watch online on Tuesday, August 13 @ 10 AM Pacific | 1 PM Eastern. This roundtable is moderated by a HCP.
The webinar will be recorded. If you would like to share it with others, the replay will be available within the next few days. To receive a link to the recording, please register and you will be notified when it’s available.
I'll be at the August 13th HCP Roundtable: Fine-Tuning CLL Dose Modification and Side Effect Management Strategies webinar. Join me! Share on XGuests
Empowering Providers to Empower Patients (EPEP) is brought to you by the Patient Empowerment Network. Funding is made possible through a sponsorship from Pharmacyclics, an AbbVie Company, and generous donations from people like you.
